N-acylneuraminate-9-phosphate synthase

From WikiMD's Wellness Encyclopedia

N-Acylneuraminate-9-phosphate synthase is an enzyme that plays a crucial role in the biosynthesis of sialic acid, a family of sugars widely distributed in animal tissues and involved in various biological processes including cell-cell interaction, microbial pathogenesis, and cancer metastasis. This enzyme catalyzes the condensation of phosphoenolpyruvate (PEP) and N-acetyl-D-mannosamine (ManNAc) to form N-acetylneuraminate-9-phosphate (Neu5Ac-9-P), an important intermediate in the sialic acid synthesis pathway.

Function[edit | edit source]

N-Acylneuraminate-9-phosphate synthase is integral to the sialic acid metabolism, facilitating the production of sialic acids which are critical for the stability and function of glycoproteins and glycolipids. Sialic acids contribute to the negative charge and hydrophilicity of the cell surface, influencing interactions with other cells and the extracellular matrix. The activity of this enzyme is essential for the proper functioning of the immune system, development of the nervous system, and modulation of inflammation.

Genetic and Molecular Basis[edit | edit source]

The enzyme is encoded by the gene NANS, which is located on human chromosome 9. Mutations in NANS can lead to sialic acid storage diseases or other metabolic disorders, highlighting the enzyme's importance in human health. The structure of N-acylneuraminate-9-phosphate synthase reveals a typical fold of the aldolase class of enzymes, which is crucial for its catalytic activity. Understanding the enzyme's structure helps in the development of inhibitors that could serve as therapeutic agents against diseases involving aberrant sialic acid synthesis.

Clinical Significance[edit | edit source]

Alterations in the activity or expression of N-acylneuraminate-9-phosphate synthase can have significant pathological consequences. For instance, increased sialylation, facilitated by this enzyme, is often observed in cancer cells and is associated with tumor invasiveness and poor prognosis. Conversely, genetic defects leading to insufficient sialic acid production can result in congenital disorders affecting development and function.

Research and Therapeutic Applications[edit | edit source]

Research on N-acylneuraminate-9-phosphate synthase is focused on understanding its role in health and disease, with the aim of developing therapeutic strategies. Inhibitors of this enzyme have potential as anti-cancer agents by preventing the over-sialylation of tumor cells. Additionally, understanding the enzyme's mechanism could lead to treatments for metabolic disorders caused by its deficiency.

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD